This Tetraphase Pharma Analyst Expects Positive Data In Mid-2015

By: via Benzinga
In a report published Tuesday, analysts at Brean Capital maintained their Buy rating on Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH). ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.